HealthCare Global Enterprises approves audited FY2025-26 results and BACC divestment
Healthcare Global Enterprises · Healthcare Services
Key highlights
- Standalone total assets Rs. 291,734 lakhs and total equity Rs. 160,478 lakhs as of 31 March 2026
- Rights issue of 8,294,566 shares at Rs. 512 allotted 27 March 2026; premium Rs. 41,639 lakhs, expenses Rs. 483 lakhs
- Acquired 51% of Vizag Hospital And Cancer Research Centre Pvt Ltd on 01 October 2024; further 34% completed 13 April 2026 for Rs. 15,450 lakhs
Why it's rated major development: the year-on-year change is 85% (20% or more for adverse news)
Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.
Original filing
Audited Financial Results For The Quarter And Year Ended March 31, 2026.
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Healthcare Global Enterprises
- Capex / expansionMajor developmentHealthcare Global Enterprises Ltd reports Q1 FY27 revenue up 13%, EBITDA up 20%
Other financial results filings this fortnight
- Siddhika Coatings Limited approves joint venture and announces H1 FY 2026 financials
- Financial resultsBrooks LaboratoriesBrooks Laboratories Limited announces Q2 and H1 FY2026 unaudited financial results
- Financial resultsBrooks LaboratoriesBrooks Laboratories Limited announces Q2 and H1 FY2027 financial results and divestment
- NHC Foods reports Sept 2026 quarter results, 99.98% firm stake, two appointments
- Spectrum Electrical Industries Ltd approves Q2 & H1 results for period ended September 30, 2026
- Dev Labtech Venture reports unaudited half-year results to 30 Sept 2026
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM QualityGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.